The DOI matches its Crossref record; 240 of the 243 references it cites were found in a registry or an index.
Therapeutic Applications of Iminosugars: Current Perspectives and Future Opportunities
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Massagué, J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.753 · Cited by 7,571
Biological roles of oligosaccharides: all of the theories are correct
Varki, A. P. (1993) · Glycobiology · doi:10.1093/glycob/3.2.97 · Cited by 5,229
Glycosylation in Cellular Mechanisms of Health and Disease
Ohtsubo, K., & Marth, J. D. (2006) · Cell · doi:10.1016/j.cell.2006.08.019 · Cited by 2,818
Glycobiology: Toward Understanding the Function of Sugars
Dwek, R. A. (1996) · Chemical Reviews · doi:10.1021/cr940283b · Cited by 2,800
Varki, A. P., Cummings, R. D., Esko, J. D., Freeze, H. H., Stanley, P., Bertozzi, C. R., Hart, G. W., & Etzler, M. E. (1999) · Cited by 2,384
Buée, L., Bussière, T., Buée‐Scherrer, V., Delacourte, A., & Hof, P. R. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00019-9 · Cited by 2,142
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
Sidransky, E., Nalls, M. A., Aasly, J. O., Aharon-Peretz, J., Annesi, G., Barbosa, E. R., Bar-Shira, A., Berg, D., Bras, J., Brice, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0901281 · Cited by 2,135
Spiro, R. G. (2002) · Glycobiology · doi:10.1093/glycob/12.4.43r · Cited by 1,414
Rademacher, T. W., Parekh, R. B., & Dwek, R. A. (1988) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.57.070188.004033 · Cited by 1,144
Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism.
Hakomori, S. (1996) · PubMed · Cited by 987
Research works printed but not linked: 17
- Nishikawa, 1965, J. Antibiotics, 18, 132
- Inouye, 1966, J. Antibiotics, 19, 288
- Ishida, 1967, Antibiotics, 20, 62
- Ishida, 1967, Antibiotics, 20, 66
- Yagi, 1976, Nippon Nogeikagaku Kaishi, 50, 571, 10.1271/nogeikagaku1924.50.11_571 · DOI
- Jacob, 2007, J. Microbiol., 45, 431
- Durantel, 2007, Curr. Opin. Investig. Drugs, 8, 125
- Hakomori, 1996, Cancer Res., 56, 5309
- Pili, 1995, Cancer Res., 55, 2920
- Oredipe, 2003, Cell Mol. Biol., 49, 1089
- Suzuki, 2008, Oncol. Rep., 3, 743
- http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=7077.
- Durantel, 2009, Curr. Opin. Investig. Drugs, 10, 860
- Love, 1994, Hum. Mol. Genet., 118, 119
- Futerman, 2004, Nat. Rev. Mol. Cell Biol., 15, 417
- Sandhoff, 1968, H. Pathol. Eur, 3, 278
- Horne, 2010, Innov. Pharmaceut. Technol., September, 64
Cited by
Sorted by citations
Iminosugars as Therapeutic Agents: Recent Advances and Promising Trends
Nash, R. J., Kato, A., Yu, C.-Y., & Fleet, G. W. J. (2011) · Future Medicinal Chemistry · doi:10.4155/fmc.11.117 · Cited by 302
Tiwari, V. K., Mishra, R. C., Sharma, A., & Tripathi, R. P. (2012) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955712803832654 · Cited by 97
Decroocq, C., Joosten, A. Y. P., Sergent, R., Barragán, T. M., Mellet, C. O., & Compain, P. (2013) · ChemBioChem · doi:10.1002/cbic.201300283 · Cited by 61
Looking-Glass Synergistic Pharmacological Chaperones: DGJ and L-DGJ from the Enantiomers of Tagatose
Jenkinson, S. F., Fleet, G. W. J., Nash, R. J., Koike, Y., Adachi, I., Yoshihara, A., Morimoto, K., Izumori, K., & Kato, A. (2011) · Organic Letters · doi:10.1021/ol201552q · Cited by 56
Mondon, M., Fontelle, N., Désiré, J., Lecornué, F., Guillard, J., Marrot, J., & Blériot, Y. (2012) · Organic Letters · doi:10.1021/ol203385w · Cited by 47
Metadata
- Authors
- Horne, G., & Wilson, F. X.
- Affiliations
- Summit (United Kingdom) (GB)
- ORCID
- Wilson, Francis X.
- Venue
- Progress in medicinal chemistry
- Publisher
- Elsevier
- Published
- 2011
- Volume
- 50
- Pages
- 135-176
- ISSN
- 0079-6468 (ISSN-L)
- OpenAlex
- W194646270
- Cited by
- 87
- References
- 243
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 1 · 2023: 5 · 2022: 2 · 2021: 5 · 2020: 6 · 2019: 8 · 2018: 7 · 2017: 2 · 2016: 9 · 2015: 7 · 2014: 11 · 2013: 8 · 2012: 6
- FWCI
- 62.01
- Type
- book chapter
- Language
- en
- Open access
- closed
- Locations
- Progress in medicinal chemistry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Chemistry › Organic Chemistry › Carbohydrate Chemistry and Synthesis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Physical Sciences › Chemistry › Organic Chemistry › Natural product bioactivities and synthesis
- Keywords
- iminosugars, carbohydrate mimetics, carbohydrate receptors, carbohydrate metabolism, chemotherapeutic target, therapeutic applications, glycosylation inhibition
- MeSH terms
- Animals, Anti-Bacterial Agents, Antineoplastic Agents, Antiviral Agents, Bacterial Infections, Humans, Metabolic Diseases, Neoplasms, Virus Diseases, Neurodegenerative Diseases, Rare Diseases, Imino Sugars, Drug Discovery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
